Committee Opinion on Zygotes Showing 2.1 Pronuclei – Reproductive BioMedicine Online
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn about a paper by Tammy Lee et al.:
“This scoping review from a team led by Tammy Lee proposes a committee opinion on zygotes showing 2.1 pronuclei (2.1PN zygotes), including a working provisional definition, to guide clinical practice and future studies.
From their analysis, the authors note that greater awareness and accurate classification of 2.1PN zygotes from true 3PN zygotes can improve embryo selection and help embryologists make better decisions for patients; otherwise, viable 2.1PN-derived embryos might have been discarded.
They suggest that, as the assisted reproductive technology field shifts from describing oocytes as ‘abnormally’ fertilised to ‘atypically’ fertilised, evidence-informed clinic policies regarding the clinical use of 2.1PN-derived embryos should evolve accordingly.
Embryos that are derived from atypical 2.1PN fertilisation patterns can increase the number of embryos available for use and give poor prognosis patients, who may not have any 2PN zygotes, an opportunity for transfer.
Published open access, the full paper is available ahead of press from the Clinical Embryology section of our November issue, now.”
Title: Clinical implications of zygotes showing 2.1 pronuclei: an ASPIRE Embryology Special Interest Group committee opinion
Authors: Tammy Lee, Diana Tain, Tiencheng Arthur Chang, Ryan Rose, Krishna Chaitanya Mantravadi, Lan Thi Thu Nguyen, Mi Kyung Chung, Keshav Malhotra, Kenji Ezoe, Sweelian Liow, Yanhe Liu.
You can read the Full Article in RBMO.
Other articles featuring Reproductive BioMedicine Online on Fertility News.
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?
-
Oct 29, 2026, 15:24Denny Sakkas: Driving Innovation in Reproductive Medicine
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF